Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast Cancer

Clinical trial NCT02120469 · COMPLETED

Trial details

NCT number: NCT02120469
Sponsor: City of Hope Medical Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Estrogen Receptor Negative HER2/Neu Negative Progesterone Receptor-negative Stage IV Breast Cancer Triple-negative Breast Carcinoma

Start date: 2014-10-01
Primary completion: 2019-03-20
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.